TrialCancer medicine2020

Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic-phase chronic myeloid leukemia based on early achievement of deep molecular response (MR

Kaichi Nishiwaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.